Our Research

Discover our recent findings, catch up with news, and review in-depth resources.

Nitrosamines Analysis

How Resolian’s experienced team identifies and quantifies trace impurities in a diverse range of materials.

Impurity Identification

How Resolian uses cutting-edge technology to identify impurities in drugs, ensuring their safety and effectiveness.

Foreign Matter Analysis: A Closer Look

How outsourcing to Resolian’s specialist team can help identify and analyze foreign matter in products to ensure safety and regulatory compliance.

Foreign Matter Analysis: Introduction

An overview of Foreign Particulate Matter (FPM) and its impact, and how Resolian can help.

Elemental Impurities

How Resolian helps ensure the safety of pharmaceutical products by providing specialized analysis to detect and measure trace impurities.

Resolian Opens Expanded State-of-the-Art Analytical Laboratory in Fordham

Resolian, a global leader providing bioanalytical, DMPK, and CMC testing services in the pharmaceutical and biopharmaceutical industry, has opened its 440m² analytical laboratory in Fordham, Cambridgeshire, UK…
Scroll to Top

Project Management

Zhiyang Zhao, Ph.D.

Chief Scientific Officer

Zhiyang Zhao, Ph.D., serves as Chief Scientific Officer (CSO) at Resolian. Dr. Zhao has over 30 years of pharmaceutical industry experience with special focus on drug metabolism and bioanalysis of small and large molecules in drug discovery and development. Dr. Zhao has previously held positions at Pfizer, GlaxoSmithKline, and Amgen. Before joining Resolian in 2015, Dr. Zhao served as Site Director of Preclinical Research at Amgen in Cambridge, Massachusetts, for over a decade. 

Currently, Dr. Zhao serves as an Adjunct Professor at the Eshelman School of Pharmacy of the University of North Carolina at Chapel Hill, North Carolina, and as Editor-in-Chief of Drug Metabolism & Bioanalysis Letters, a journal by Bentham Science, which publishes in all areas of drug metabolism and bioanalysis. Dr. Zhao received his Ph.D. degree in Medicinal Chemistry from Virginia Polytechnic and State University (popularly known as Virginia Tech) in Blacksburg, Virginia. 

Patrick Bennett

Chief Executive Officer

Patrick Bennett has over 35 years of experience in pharmaceutical analysis and laboratory management. Now CEO at Resolian, Patrick’s experience includes the roles of Strategic Marketing Director for Pharma with Thermo Fisher Scientific, LabCorp, and Vice President of Strategy and Development with PPD. 

Patrick earned a B.S. degree in Toxicology and a M.S. degree in Pharmacology from the College of Pharmacy and Allied Health at St. John’s University and an M.B.A in International Marketing from the Martin J. Whitman School of Management at Syracuse University.